Development of Fluorescent False Neurotransmitters
荧光假神经递质的开发
基本信息
- 批准号:8976879
- 负责人:
- 金额:$ 62.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-18 至 2020-02-29
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAcuteAddressAmphetaminesAnxietyAreaArousalAttentionAttention deficit hyperactivity disorderAxonBehavioralBiologicalBiological AssayBrainBrain DiseasesCalciumCell Culture TechniquesCellsCentral Nervous System DiseasesCharacteristicsCognitionCollaborationsCorpus striatum structureCoupledDataDevelopmentDiseaseDisease modelDopamineDorsalDrug AddictionDrug abuseElectric StimulationEmotionsFiberFluorescenceFutureHealthHippocampus (Brain)ImageImageryIndividualInterdisciplinary StudyKineticsLabelLaboratoriesLeadLearningLibrariesLifeMeasuresMental DepressionMental disordersMethodsMicroscopicMicroscopyMolecular ProbesMonitorMood DisordersMusNeurobiologyNeurologicNeuronsNeurosciencesNeurotransmittersNorepinephrineOperative Surgical ProceduresOpticsOrganic ChemistryParkinson DiseasePathologyPharmaceutical PreparationsPhasePhysiologicalPlayPreparationPresynaptic TerminalsProcessPropertyRegulationResearchRewardsRodentRodent DiseasesRoleSchizophreniaSensorySerotoninSignal TransductionSliceSomatosensory CortexStagingStressSubstantia nigra structureSynapsesSynaptic VesiclesSynaptic plasticitySystemTimeTracerVaricosityVentral Tegmental Areaarea striatabarrel cortexcalcium indicatordensitydesigndopamine systemdopamine transporterdopaminergic neuronimaging agentimaging modalityin vivoin vivo imagingmedian forebrain bundlemethod developmentmonoaminemulti-photonnervous system disorderneural circuitneurochemistryneuronal cell bodyneuropsychiatryneurotransmissionneurotransmitter releasenoradrenaline transporternovelnovel strategiesoptical imagingoptogeneticspresynapticprogramspublic health relevancereceptorresearch studysensorserotonin transportersomatosensorysynaptic functiontooltool developmenttreatment effectvesicular monoamine transporter 2voltage
项目摘要
DESCRIPTION (provided by applicant): Monoamine neurotransmitters (dopamine, norepinephrine, and serotonin) play important roles in modulating the strength of both excitatory and inhibitory neurotransmission via activation of the corresponding receptors. Monoamine neurons project their axons throughout the brain and regulate diverse brain functions including arousal, stress, emotion, reward, learning, and cognition. On a cellular level, monoamines modulate responsiveness of the target cells and synapses. Aberrations in monoamine neurotransmission have been implicated in numerous neurological and neuropsychiatric disorders including Parkinson's disease, schizophrenia, ADHD, drug addiction, depression, and anxiety. However, due to methodological limitations, monoamine neurotransmission have only been studied on the bulk level of large ensembles of monoaminergic synapses. There have been no experimental tools to examine the monoamine release characteristics of individual presynaptic boutons, a fundamental physiological parameter. Drs. Dalibor Sames (PI-1) and David Sulzer (PI-2) established an interdisciplinary research program focused on addressing this challenge. Specifically, optical probes termed "Fluorescent False Neurotransmitters" (FFNs) were designed as tracers of dopamine. This new application aims to expand the scope of the FFN concept to the entire monoamine system, many different brain areas, and living rodents. We propose to develop FFN probes selective for norepinephrine and serotonin synapses, and in vivo microscopic imaging methods applicable in living rodents. The proposed new imaging methods will enable, for the first time, visualization of synaptic content release at individual presynaptic terminals of specific neurochemical types in vivo in several brain areas (striatum, somatosensory cortex, hippocampus). These new probes and associated imaging methods will unlock the possibility of addressing many long-standing questions about release properties of single synapses and their physiological regulation and deregulation in rodent disease models. The FFN probes are compatible with the existing calcium and voltage sensors and thus jointly these tools will provide a more complete readout of synaptic function and plasticity in intact circuitry.
描述(由申请人提供):单胺神经递质(多巴胺、去甲肾上腺素和血清素)通过激活相应的受体将其轴突投射到整个大脑并调节不同的大脑功能,在调节兴奋性和抑制性神经传递的强度方面发挥着重要作用。包括唤醒、压力、情绪、奖励、学习和认知。在细胞水平上,单胺调节靶细胞的反应性。单胺神经传递的异常与许多神经和神经精神疾病有关,包括帕金森病、精神分裂症、注意力缺陷多动症、药物成瘾、抑郁症和焦虑症,然而,由于方法学的限制,单胺神经传递仅在大量水平上进行了研究。单胺能突触的集合还没有实验工具来检查单个突触前突触的单胺释放特征,这是一个基本的生理参数。 Dalibor Sames 博士 (PI-1) 和 David Sulzer (PI-2) 建立了一个跨学科研究计划,专注于解决这一挑战,具体而言,称为“荧光假神经递质”(FFN) 的光学探针被设计为多巴胺的示踪剂。该应用旨在将 FFN 概念的范围扩展到整个单胺系统、许多不同的大脑区域和活体啮齿动物。我们建议开发对去甲肾上腺素和去甲肾上腺素具有选择性的 FFN 探针。血清素突触和适用于活体啮齿动物的体内显微成像方法将首次实现体内多个大脑区域(纹状体、体感)特定神经化学类型的单个突触前末端释放的突触内容释放的可视化。这些新的探针和相关的成像方法将解决许多长期存在的问题的可能性,这些问题涉及单个突触的释放特性及其生理调节和放松管制。 FFN 探针与现有的钙和电压传感器兼容,因此这些工具将共同提供完整电路中突触功能和可塑性的更完整的读数。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DALIBOR SAMES其他文献
DALIBOR SAMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DALIBOR SAMES', 18)}}的其他基金
Chemistry and Pharmacology of Iboga Alkaloids
Iboga 生物碱的化学和药理学
- 批准号:
10594417 - 财政年份:2020
- 资助金额:
$ 62.74万 - 项目类别:
Chemistry and Pharmacology of Iboga Alkaloids
Iboga 生物碱的化学和药理学
- 批准号:
10179354 - 财政年份:2020
- 资助金额:
$ 62.74万 - 项目类别:
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
大脑中传感器和药理学探针的化学靶向
- 批准号:
10555221 - 财政年份:2020
- 资助金额:
$ 62.74万 - 项目类别:
Chemistry and Pharmacology of Iboga Alkaloids
Iboga 生物碱的化学和药理学
- 批准号:
10370433 - 财政年份:2020
- 资助金额:
$ 62.74万 - 项目类别:
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
大脑中传感器和药理学探针的化学靶向
- 批准号:
10337084 - 财政年份:2020
- 资助金额:
$ 62.74万 - 项目类别:
Development of Fluorescent False Neurotransmitters
荧光假神经递质的开发
- 批准号:
9069526 - 财政年份:2015
- 资助金额:
$ 62.74万 - 项目类别:
Development of Fluorescent False Neurotransmitters
荧光假神经递质的开发
- 批准号:
10636618 - 财政年份:2015
- 资助金额:
$ 62.74万 - 项目类别:
Development of Fluorescent False Neurotransmitters
荧光假神经递质的开发
- 批准号:
10393031 - 财政年份:2015
- 资助金额:
$ 62.74万 - 项目类别:
Design of Molecular Probes For Optical Imaging of Dopamine Neurotransmission
多巴胺神经传递光学成像分子探针的设计
- 批准号:
8403779 - 财政年份:2010
- 资助金额:
$ 62.74万 - 项目类别:
Design of Molecular Probes For Optical Imaging of Dopamine Neurotransmission
多巴胺神经传递光学成像分子探针的设计
- 批准号:
7886923 - 财政年份:2010
- 资助金额:
$ 62.74万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Role of Primary Sensory Neuron CaMKII Signaling in Regulation of Pain
初级感觉神经元 CaMKII 信号传导在疼痛调节中的作用
- 批准号:
10656886 - 财政年份:2023
- 资助金额:
$ 62.74万 - 项目类别:
High content analgesic screening from human nociceptors
从人类伤害感受器中筛选高含量镇痛剂
- 批准号:
10578042 - 财政年份:2023
- 资助金额:
$ 62.74万 - 项目类别:
Elucidation of Nanostructure and Function of Spontaneous GABAergic Transmission at the Inhibitory Synapse
抑制性突触自发 GABA 能传递的纳米结构和功能的阐明
- 批准号:
10750025 - 财政年份:2023
- 资助金额:
$ 62.74万 - 项目类别:
Prefrontal circuit mechanisms of repetitive transcranial magnetic stimulation
重复经颅磁刺激的前额电路机制
- 批准号:
10649292 - 财政年份:2023
- 资助金额:
$ 62.74万 - 项目类别: